Results
1
Companies which are potentially undervalued and in an acceptable financial position.
1 companies
Pharming Group
Market Cap: €682.7m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€1.00
7D
-2.5%
1Y
35.9%